Notably, the intracellular protein levels of SETD1A are upregulated in other breast cancer subtypes, including ER-positive, HER2-positive, and TNBC breast cancer compared with normal breast cancer cells, and miR-1915-3p regulates this process. Here, SETD1A is linked to breast carcinoma.